Research

Research provides valuable insights that allow us to continuously innovate and improve our treatments.

Continuous innovation

Research into our program

We believe in the importance of keeping our program innovative and continuously improving. That’s why we conduct scientific research alongside our treatments. Research helps us better understand the impact of our approaches and expand their availability. We have obtained a declaration for this from the Medical Ethics Review Committee (METC) and have an official collaboration with Radboud University Nijmegen. Our research team is led by Prof. Dr. Rutger Engels.

Effectiveness of Ketamine-Assisted Psychotherapy

We specifically study the mechanisms of action and the effectiveness of ketamine-assisted psychotherapy (KAP). KAP is an innovative form of treatment that combines the administration of ketamine with psychotherapeutic support. While there is already a significant body of scientific research on the effects of ketamine for treatment-resistant depression, much remains to be learned about the combination of ketamine and psychotherapy—for instance, regarding the potential added value of psychotherapeutic support, the underlying mechanisms of action, and the types of clients for whom this approach is most suitable. For this reason, we offer KAP to clients within a research context.

Senz aims to contribute to this field. We therefore systematically collect data on factors such as treatment outcomes, patient experiences, safety, and potential mechanisms of action. In doing so, we collaborate closely with Dutch universities and medical centers, such as Erasmus University Rotterdam and Radboud University Nijmegen.

We will share our research findings through scientific publications and make them available on our website.

Client referral

If you want to refer the client to also follow Ketamine Assited Psychotherapy (KAP) treatment with us, please also include the answers to the following questions in the referral:

  • Is there a mood disorder, and has treatment already taken place for the mood disorder?

If so:

  • Which and during which period did the client receive psychopharmaceutical treatment?
  • Which, where, and during which period did the client receive psychotherapeutic treatment?

Research into the effectiveness of KAP

We specifically study the mechanisms of action and the effectiveness of ketamine-assisted psychotherapy (KAP). KAP is an innovative form of treatment that combines the administration of ketamine with psychotherapeutic support. While there is already a significant body of scientific research on the effects of ketamine for treatment-resistant depression, much remains to be learned about the combination of ketamine and psychotherapy—for instance, regarding the potential added value of psychotherapeutic support, the mechanisms of action, and the types of clients for whom this approach is most suitable. For this reason, we offer KAP to clients within a research context.

We therefore systematically collect data on factors such as treatment outcomes, patient experiences, safety, and potential mechanisms of action. In doing so, we collaborate closely with Dutch universities and medical centers, such as Erasmus University Rotterdam and Radboud University Nijmegen.

We will share our research findings through scientific publications and also make them available on our website.